/PRNewswire/ -- Sequentify is pleased to announce the appointment of Dr. Ravi Majeti, a world-renowned expert in hematologic malignancies, as Scientific...
Management Changes
/PRNewswire/ -- Sequentify and Bio Molecular Systems (BMS) today announced the release of the InfiniSeq™ Protocol for the Myra® liquid handling system, now...
PartnersProduct Stage
/PRNewswire/ -- Sequentify is offering research grants to accelerate high-impact genomic studies through its uniquely fast, easy-to-use, and scalable targeted...
/PRNewswire/ -- The Hematology Laboratory, Molecular Hematology Unit, at Sheba Medical Center, Israel's largest medical center, is conducting a joint study...
Partners
/PRNewswire/ -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library preparation solutions to Romania. This...
Partners
Sequentify Awarded Grant by Israel Innovation Authority for Infectious Disease Sequencing Panel
Investment
Stanford to use Sequentify kits for Hematological Malignancies NGS Sequencing
Partners
Sequentify collaborates with Yeda, the commercial arm of the Weizmann Institute, under an NIH grant for evaluating the effect of clonal hematopoiesis on cognitive impairment and kidney function decline
Partners
Democratizing Genomics, Sequentify Raises $7M to Enable DNA Sequencing at Scale
InvestmentCustomers
